Wolters Kluwer will acquire AgileMD for up to $100 million to combine clinical AI tools with UpToDate in hospital workflows.

Wolters Kluwer agrees to buy AgileMD for $100M

Wolters Kluwer agrees to buy AgileMD for $100M

Image: AI-generated editorial illustration

Wolters Kluwer Health said on November 13, 2026, that it signed an agreement to acquire San Francisco-based AgileMD, a healthcare technology startup focused on AI-powered clinical decision support for hospitals. The deal is valued at up to $100 million and is expected to close in the first quarter of 2027 or sooner, subject to customary closing conditions and governmental approvals.

Wolters Kluwer Health said on November 13, 2026, that it signed an agreement to acquire San Francisco-based AgileMD, a healthcare technology startup focused on AI-powered clinical decision support for hospitals. The deal is valued at up to $100 million and is expected to close in the first quarter of 2027 or sooner, subject to customary closing conditions and governmental approvals.

What is Wolters Kluwer buying?

Wolters Kluwer is buying AgileMD, a company founded in 2011 that builds AI-powered clinical decision support software for healthcare providers. AgileMD says its platform combines FDA-cleared AI with embedded decision support to help care teams identify high-risk patients and act inside hospital workflows.

The company's best-known product is eCART, which AgileMD says uses FDA-cleared AI to flag patients at risk of all-cause clinical deterioration. According to AgileMD, eCART was trained and tested on nearly 3 million patient encounters across 28 hospitals in six health systems, and it was retrospectively and prospectively validated on sepsis, COPD, CHF, and COVID populations.

AgileMD also offers Pathways, a product that gives care teams access to updated protocols within their workflows, including order entry and documentation. The company says more than 4,800 Pathways are live at partner institutions, its platform has handled more than 4.425 million patient encounters, and it has more than 150,000 clinical users.

How much is the deal worth?

The announced consideration is up to $100 million, with $40 million paid upfront and the remainder deferred and contingent on AgileMD reaching specified performance targets. Wolters Kluwer said the acquisition is expected to have an immaterial effect on adjusted earnings.

The company also said it expects the transaction to generate a return on invested capital at or above its 8% after-tax weighted average cost of capital within three to five years. That is a financial hurdle for the deal rather than an immediate operating result, and it reflects Wolters Kluwer's view of the asset's long-term economics.

Unite.AI reported that all 23 AgileMD employees are expected to join Wolters Kluwer Health, though the companies' formal announcement did not provide that staffing detail. The same report said the transaction had not yet closed and remained subject to standard approvals and closing conditions.

Why does Wolters Kluwer want AgileMD?

Wolters Kluwer said the acquisition is designed to help healthcare systems improve patient care and get more value from technology investments. AgileMD's tools are built to live inside electronic health record workflows, which matters because hospitals often want clinical guidance and patient-risk alerts without forcing clinicians to switch between multiple systems.

Unite.AI reported that Pathways brings health-system guidelines into EHR workflows, including order entry, order sets, documentation, and the use of laboratory and vital-sign data. That workflow integration appears to fit Wolters Kluwer's broader strategy around digital clinical support.

Unite.AI also reported that Wolters Kluwer intends to combine AgileMD with UpToDate Expert AI, which the outlet said was introduced in September 2025. Wolters Kluwer says UpToDate Expert AI has been adopted by more than 2,700 U.S. hospitals and health systems, representing more than 95% of its U.S.-based UpToDate Enterprise Edition customers.

AgileMD CEO Borna Safabakhsh said joining Wolters Kluwer would help accelerate and streamline the development and maintenance of more advanced clinical pathways. Wolters Kluwer executive Yaw Fellin said the acquisition is intended to help healthcare systems improve patient care and get more value from technology investments.

What happens next?

The deal is still pending and is expected to close in the first quarter of 2027 or sooner, subject to customary closing conditions and governmental approvals. Until then, Wolters Kluwer and AgileMD remain separate companies.

If the transaction closes as announced, Wolters Kluwer will add a hospital-focused clinical AI product set with FDA-cleared risk detection and workflow-integrated pathways and, according to Unite.AI, AgileMD's 23 employees are expected to join Wolters Kluwer Health. For Wolters Kluwer, the acquisition extends a product lineup that already reaches a large share of U.S. UpToDate Enterprise Edition customers and gives it another way to embed decision support deeper into hospital care workflows.

Sources